Teva Announces Exclusive Launch of Generic Viagra® Tablets in the United States

Business Wire Monday, 11 December 2017 ()
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive launch of its generic Viagra®1 (sildenafil citrate) tablets in the U.S. Sildenafil tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED). “The launch of Teva’s sildenafil tablets brings an affordable generic treatment option to the estimated 18 million men in the U.S. who are diagnosed with erectile dysfunction,” said Brendan
👓 View on full article
0
shares		Share on
FacebookShare on
TwitterPost on 
RedditShare by
Email